secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prelude Therapeutics Inc (PRLD)
CIK:        0001678660
Form:       8-K
Filed at:   2023-02-14T23:59:59+00:00
Accession:  0000950170-23-002729
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prelude Therapeutics posts investor presentation for SVB Global Biopharma Conference
--------------------------------------------------------------------------------

- Filed investor presentation under Regulation FD for Feb 2023 SVB conference.
- Presentation attached as Exhibit 99.1 with no specific financial or clinical details in filing body.
- No new material events, guidance changes, or operational updates disclosed in the 8-K text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1678660/000095017023002729/0000950170-23-002729-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1678660/000095017023002729/prld-20230214.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-002729

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer